Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Scholar Rock Holding Corp (SRRK)

Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Feb 17, 2026
Sale
Shares
7,989
Price
$46.53
Total Value
$371.71K
Shares Held After
106,929
% of Holdings
7.0%

Scholar Rock Holding Corp (SRRK)

Ho Junlin — GENERAL COUNSEL
Feb 17, 2026
Sale
Shares
9,580
Price
$46.53
Total Value
$445.74K
Shares Held After
241,545
% of Holdings
3.8%
Feb 17, 2026
Sale
Shares
9,035
Price
$46.53
Total Value
$420.38K
Shares Held After
169,087
% of Holdings
5.1%

Scholar Rock Holding Corp (SRRK)

Marantz Jing L. — CHIEF MEDICAL OFFICER
Feb 17, 2026
Sale
Shares
4,157
Price
$46.53
Total Value
$193.42K
Shares Held After
126,012
% of Holdings
3.2%
Feb 17, 2026
Sale
Shares
93
Price
$27.18
Total Value
$2.53K
Shares Held After
379,786
% of Holdings
0.0%
Feb 17, 2026
Sale
Shares
3,272
Price
$26.29
Total Value
$86.04K
Shares Held After
379,879
% of Holdings
0.9%
Feb 17, 2026
Sale
Shares
11,635
Price
$25.39
Total Value
$295.46K
Shares Held After
383,151
% of Holdings
2.9%

Inotiv, Inc. (NOTV)

Leasure Robert Jr. — Director
Feb 17, 2026
Sale
Shares
16,810
Price
$0.30
Total Value
$4.96K
Shares Held After
1,256,215
% of Holdings
1.3%

Inotiv, Inc. (NOTV)

Sagartz John E — Chief Strategy Officer
Feb 17, 2026
Sale
Shares
2,119
Price
$0.29
Total Value
$616.21
Shares Held After
735,697
% of Holdings
0.3%

Inotiv, Inc. (NOTV)

Taylor Beth A. — Chief Financial Officer
Feb 17, 2026
Sale
Shares
2,888
Price
$0.29
Total Value
$845.90
Shares Held After
145,480
% of Holdings
1.9%

ENSIGN GROUP, INC (ENSG)

Shaw Daren — Director
Feb 17, 2026
Sale
Shares
1,000
Price
$213.43
Total Value
$213.43K
Shares Held After
23,726
% of Holdings
4.0%

Karyopharm Therapeutics Inc. (KPTI)

Poulton Stuart — EVP, Chief Development Officer
Feb 17, 2026
Sale
Shares
378
Price
$8.63
Total Value
$3.26K
Shares Held After
99,429
% of Holdings
0.4%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Ambrose Kristen — SVP & Chief Accounting Officer
Feb 17, 2026
Sale
Shares
1,557
Price
$489.46
Total Value
$762.09K
Shares Held After
8,388
% of Holdings
15.7%

Twist Bioscience Corp (TWST)

Finn Patrick John — President and COO
Feb 17, 2026
Sale
Shares
3,541
Price
$53.11
Total Value
$188.06K
Shares Held After
287,788
% of Holdings
1.2%

Twist Bioscience Corp (TWST)

Finn Patrick John — President and COO
Feb 17, 2026
Sale
Shares
26,952
Price
$52.69
Total Value
$1.42M
Shares Held After
291,329
% of Holdings
8.5%

Twist Bioscience Corp (TWST)

Finn Patrick John — President and COO
Feb 17, 2026
Sale
Shares
16,616
Price
$51.42
Total Value
$854.44K
Shares Held After
318,281
% of Holdings
5.0%

Twist Bioscience Corp (TWST)

Finn Patrick John — President and COO
Feb 17, 2026
Sale
Shares
21,858
Price
$50.32
Total Value
$1.10M
Shares Held After
334,897
% of Holdings
6.1%

Twist Bioscience Corp (TWST)

Green Paula — SVP of Human Resources
Feb 17, 2026
Sale
Shares
39,404
Price
$52.40
Total Value
$2.06M
Shares Held After
126,041
% of Holdings
23.8%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Feb 17, 2026
Sale
Shares
2,031
Price
$489.46
Total Value
$994.09K
Shares Held After
21,544
% of Holdings
8.6%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Biller Jonathan — EVP and Chief Legal Officer
Feb 17, 2026
Sale
Shares
2,476
Price
$489.46
Total Value
$1.21M
Shares Held After
16,992
% of Holdings
12.7%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Feb 17, 2026
Sale
Shares
4,321
Price
$28.26
Total Value
$122.12K
Shares Held After
105,211
% of Holdings
3.9%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Feb 17, 2026
Sale
Shares
5,679
Price
$27.50
Total Value
$156.20K
Shares Held After
109,532
% of Holdings
4.9%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Bunnage Mark E. — EVP, Chief Scientific Officer
Feb 17, 2026
Sale
Shares
2,437
Price
$489.46
Total Value
$1.19M
Shares Held After
9,668
% of Holdings
20.1%

Ceribell, Inc. (CBLL)

Parvizi Josef — Director
Feb 17, 2026
Sale
Shares
1,300
Price
$20.00
Total Value
$26.00K
Shares Held After
746,352
% of Holdings
0.2%

JOHNSON & JOHNSON (JNJ)

Broadhurst Vanessa — EVP, Global Corp Affairs
Feb 17, 2026
Sale
Shares
6,197
Price
$243.39
Total Value
$1.51M
Shares Held After
23,003
% of Holdings
21.2%

JOHNSON & JOHNSON (JNJ)

REED JOHN C — EVP, Innovative Medicine, R&D
Feb 17, 2026
Sale
Shares
2,283
Price
$243.00
Total Value
$554.77K
Shares Held After
10,658
% of Holdings
17.6%

JOHNSON & JOHNSON (JNJ)

REED JOHN C — EVP, Innovative Medicine, R&D
Feb 17, 2026
Sale
Shares
29,927
Price
$243.00
Total Value
$7.27M
Shares Held After
12,941
% of Holdings
69.8%

JOHNSON & JOHNSON (JNJ)

REED JOHN C — EVP, Innovative Medicine, R&D
Feb 17, 2026
Sale
Shares
21,721
Price
$243.00
Total Value
$5.28M
Shares Held After
12,941
% of Holdings
62.7%

JOHNSON & JOHNSON (JNJ)

Wolk Joseph J — Exec VP, CFO
Feb 17, 2026
Sale
Shares
24,961
Price
$242.68
Total Value
$6.06M
Shares Held After
14,000
% of Holdings
64.1%

JOHNSON & JOHNSON (JNJ)

Wolk Joseph J — Exec VP, CFO
Feb 17, 2026
Sale
Shares
33,386
Price
$242.75
Total Value
$8.10M
Shares Held After
38,961
% of Holdings
46.1%

JOHNSON & JOHNSON (JNJ)

Wolk Joseph J — Exec VP, CFO
Feb 17, 2026
Sale
Shares
12,066
Price
$242.87
Total Value
$2.93M
Shares Held After
38,961
% of Holdings
23.6%

JOHNSON & JOHNSON (JNJ)

Wolk Joseph J — Exec VP, CFO
Feb 17, 2026
Sale
Shares
19,241
Price
$242.99
Total Value
$4.68M
Shares Held After
38,961
% of Holdings
33.1%
Feb 17, 2026
Sale
Shares
20,521
Price
$242.70
Total Value
$4.98M
Shares Held After
25,698
% of Holdings
44.4%

Adagio Therapeutics, Inc. (ADGI)

Andersen Jill — Chief Legal Officer, Secretary
Feb 17, 2026
Sale
Shares
32,771
Price
$1.54
Total Value
$50.45K
Shares Held After
216,675
% of Holdings
13.1%

Adagio Therapeutics, Inc. (ADGI)

Lee Timothy Edward — Chief Commercial Officer
Feb 17, 2026
Sale
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
138,681
% of Holdings
12.4%

Adagio Therapeutics, Inc. (ADGI)

Duke William E. — Chief Financial Officer
Feb 17, 2026
Sale
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
128,681
% of Holdings
13.3%

EXELIXIS, INC. (EXEL)

Haley Patrick J. — EVP, Commercial
Feb 17, 2026
Sale
Shares
64,778
Price
$43.50
Total Value
$2.82M
Shares Held After
381,908
% of Holdings
14.5%

EXELIXIS, INC. (EXEL)

Haley Patrick J. — EVP, Commercial
Feb 17, 2026
Sale
Shares
3,036
Price
$43.84
Total Value
$133.10K
Shares Held After
446,686
% of Holdings
0.7%
Feb 17, 2026
Sale
Shares
30,617
Price
$43.67
Total Value
$1.34M
Shares Held After
976,092
% of Holdings
3.0%

Adagio Therapeutics, Inc. (ADGI)

Green Julie — Chief Human Resources Officer
Feb 17, 2026
Sale
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
128,681
% of Holdings
13.3%

Adagio Therapeutics, Inc. (ADGI)

Allen Robert D. III — Chief Scientific Officer
Feb 17, 2026
Sale
Shares
18,189
Price
$1.54
Total Value
$28.00K
Shares Held After
133,879
% of Holdings
12.0%

SI-BONE, Inc. (SIBN)

RECUPERO ANTHONY J — Former President, Commercial Operations
Feb 17, 2026
Sale
Shares
3,065
Price
$15.45
Total Value
$47.36K
Shares Held After
243,418
% of Holdings
1.2%

SI-BONE, Inc. (SIBN)

RECUPERO ANTHONY J — Former President, Commercial Operations
Feb 17, 2026
Sale
Shares
11,143
Price
$15.41
Total Value
$171.67K
Shares Held After
246,483
% of Holdings
4.3%

SI-BONE, Inc. (SIBN)

RECUPERO ANTHONY J — Former President, Commercial Operations
Feb 17, 2026
Sale
Shares
1,710
Price
$15.41
Total Value
$26.35K
Shares Held After
257,626
% of Holdings
0.7%

SI-BONE, Inc. (SIBN)

RECUPERO ANTHONY J — Former President, Commercial Operations
Feb 17, 2026
Sale
Shares
3,040
Price
$15.42
Total Value
$46.86K
Shares Held After
259,336
% of Holdings
1.2%

SI-BONE, Inc. (SIBN)

RECUPERO ANTHONY J — Former President, Commercial Operations
Feb 17, 2026
Sale
Shares
2,091
Price
$15.28
Total Value
$31.95K
Shares Held After
262,376
% of Holdings
0.8%

BridgeBio Pharma, Inc. (BBIO)

Trimarchi Thomas — President and CFO
Feb 17, 2026
Sale
Shares
200
Price
$75.38
Total Value
$15.08K
Shares Held After
336,585
% of Holdings
0.1%

BridgeBio Pharma, Inc. (BBIO)

Trimarchi Thomas — President and CFO
Feb 17, 2026
Sale
Shares
13,400
Price
$74.71
Total Value
$1.00M
Shares Held After
336,785
% of Holdings
3.8%

BridgeBio Pharma, Inc. (BBIO)

Apuli Maricel — Chief Accounting Officer
Feb 17, 2026
Sale
Shares
510
Price
$74.31
Total Value
$37.90K
Shares Held After
123,945
% of Holdings
0.4%
Feb 17, 2026
Sale
Shares
4,083
Price
$39.80
Total Value
$162.50K
Shares Held After
288,976
% of Holdings
1.4%
Version: v26.3.33